Company / Financials
BioCorRx Inc. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$797.2K
FY2025 · +10301.1% YoY
Net Income
-$3.4M
FY2025 · +32.6% YoY
Profit Margin
-431.5%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$2.1M
FY2025
Total Debt
-
FY2025
Equity
-$11.2M
FY2025
ROA
-160.2%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -43.66 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$797.2K+10301.1% YoYNet Income HistoryProfit after all expenses and taxes-$3.4M+32.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-$4.8M+5.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.8M+5.0% YoYR&D Expense HistoryResearch and development spending$1.8M+19.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$223.8K-71.2% YoYIncome Tax HistoryTotal income tax expense$0EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.49Shares Outstanding HistoryWeighted average diluted shares outstanding13.3M+53.3% YoY